Business Wire – It is expected that the overall market for Radiopharmaceuticals in 2019 will touch 6.1 billion US dollars. SPECT Radioisotopes among all radiopharmaceuticals constitute the single largest product type. Demand for which is expected to reach $2.7 billion US dollars in 2019. The beta emitting radionuclides are projected to be the fastest growing radiopharmaceuticals product type. The rising prevalence of non-communicative diseases, especially cancer and cardiovascular diseases are the main factors driving the radiopharmaceutical market.
To read more please visit:
Source: Business Wire